Jasper Therapeutics: offers $0.324 cash per warrant

What happened On Oct 7, 2026, Jasper Therapeutics, Inc. issued a press release announcing that it has commenced an offer to each holder of its outstanding warrants to purchase shares of its common stock that were issued in the company’s underwritten public offering on Sep 18, 2025. Under the offer, each holder may receive $0.324 in cash, without interest, for each outstanding warrant the holder tenders. Each warrant entitles its holder to purchase one share of common stock at an exercise price of $2.92, subject to adjustment. As of Oct 6, 2026, 12,345,707 warrants were outstanding. The offer is made on the terms in an Offer to Purchase dated Oct 7, 2026, and will be open until one minute after 11:59 p.m., Eastern Time, on Nov 6, 2026, or any later date the company may extend it.

Key details

• Offer cash price: $0.324 per outstanding warrant, without interest.
• Warrant exercise price: $2.92 per share, subject to adjustment.
• Warrants outstanding as of Oct 6, 2026: 12,345,707.
• Offer open until one minute after 11:59 p.m., Eastern Time, on Nov 6, 2026 (or extended).

Why it may matter This report was filed under Item 8.01 (other events) and describes the company’s commencement of the offer to purchase outstanding warrants. This filing does not show why the insider traded or why the company acted.